Frailty is associated with increased mortality among lung transplant candidates. We sought to determine the association between frailty, as measured by the Short Physical Performance Battery (SPPB), and mortality after lung transplantation. In a multicenter prospective cohort study of adults who underwent lung transplantation, preoperative frailty was assessed with the SPPB (n = 318) and, in a secondary analysis, the Fried Frailty Phenotype (FFP; n = 299). We tested the association between preoperative frailty and mortality following lung transplantation with propensity score-adjusted Cox models. We calculated postestimation marginalized standardized risks for 1-year mortality by frailty status using multivariate logistic regression.
SPPB frailty was associated with an increased risk of both 1-and 4-year mortality (adjusted hazard ratio [aHR]: 7.5; 95% confidence interval [CI]: 1.6-36.0 and aHR 3.8; 95%CI: 1.8-8.0, respectively). Each 1-point worsening in SPPB was associated with a 20% increased risk of death (aHR: 1.20; 95%CI: 1.08-1.33). Frail subjects had an absolute increased risk of death within the first year after transplantation of 12.2%
| INTRODUC TI ON
Lung transplantation aims to extend survival, reduce disability, and improve health-related quality of life for persons with advanced lung diseases. Despite stringent selection criteria and advances in surgical and medical therapies, mortality after lung transplantation is high and has not improved in the last 5 years.
1
A 2005 overhaul in the US donor lung organ allocation system aimed to reduce an unacceptably high waitlist mortality.
2 While achieving its primary aim, a consequence of the Lung Allocation Score (LAS) system is that older and sicker candidates are prioritized for transplantation. As a result, older adults (age ≥65) are the fastest growing group of lung transplant candidates in the United States, now accounting for nearly 30% of new transplant recipients compared to only 4% in 2002. 1 After lung transplantation, those 65 years and older have a median survival of only 3.6 years, fully 3 years less than those 35-49 years old. 3 This rapid trend has outpaced the evidence base, and data are needed to identify which candidates will do well after lung transplantation. Absent better approaches, transplant programs have adopted admittedly arbitrary age cutoffs or "eyeball tests" of fitness to identify suitable candidates. Although known risk factors for death such as age, functional status, oxygen use, and others are already incorporated into LAS, increasing waitlist mortality rates and persistently high mortality after lung transplantation underscore the need to identify novel, ideally modifiable, risk factors for poor outcomes.
1 Doing so will help to maximize the individual and societal benefit of a scarce resource such as lung transplantation. 2 We recently identified physical frailty as a novel risk factor for disability and death prior to transplant in lung transplant candidates. 4 Originally a geriatric construct, frailty reflects accumulated aging-related deficits across multiple systems that attenuate the body's physiologic reserve. This results in a "state-of-risk" for disproportionate declines in health status upon exposure to an additional physiologic stressor. 5 Frailty is a risk factor for disability, perioperative complications, and mortality in older medical and surgical populations [6] [7] [8] [9] [10] [11] [12] [13] [14] including abdominal organ transplantation. 4, [15] [16] [17] [18] [19] Furthermore, frailty, defined by an accumulation of deficits, is associated with mortality after lung transplantation.
19
Whether preoperative physical frailty is a novel risk factor for mortality following lung transplantation, however, is unknown. In this multicenter prospective cohort study, we aimed to determine whether preoperative physical frailty quantified primarily by the Short Physical Performance Battery (SPPB) and, secondarily, by the Fried Frailty phenotype (FFP), was associated with an increased risk of death after lung transplantation.
| ME THODS

| Study design, participants, and setting
We analyzed participants in the Lung Transplant Body Composition (LTBC) study. LTBC is a multicenter observational prospective cohort study investigating the impact of preoperative body composition and physical frailty on outcomes in lung transplant candidates and recipients. We excluded candidates for multiorgan or redo lung transplantation. For this analysis, candidates for lung transplantation age ≥18 years at the University of California, San Francisco (UCSF), Columbia University Medical Center (CUMC), and the University of Pennsylvania were recruited. As reported previously, in the early phase of this study (2010) (2011) (2012) , UCSF was utilizing the SPPB and CUMC was utilizing the FFP to quantify physical frailty (detailed below). 4 After 2012, centers began collecting both measures; as a result, not all subjects completed both frailty measures. The overall study period ranged between February 2010 and May 2017.
Institutional Review Boards at each center approved this study and participants provided written informed consent for participation.
| Frailty assessment
We tested 2 well-validated frailty measures that emphasize physical functioning and that we previously found to be associated with death or removal from the waitlist in lung transplant candidates.
4
Although our previous work and new findings in kidney transplantation suggest that the SPPB may be superior to the FFP, there is equipoise in regard to survival after lung transplantation. 4, 20 Details on the frailty measures and scoring are in Table S1 . For this analysis, we defined the SPPB as our primary measure of frailty and, in secondary analyses, defined frailty by the FFP. Frailty assessments were performed around the time of listing and, as possible, every 3 months while subjects were listed. Those assessments most proximal to the time of transplant were used for this analysis. The SPPB is a 3-component battery that includes gait speed, chair stands, and balance. 6, 7 Each measure is scored from 0 to 4 with an aggregate (95%CI: 3.1%-21%). In secondary analyses, FFP frailty was associated with increased risk of death within the first postoperative year (aHR: 3.8; 95%CI: 1.1-13.2) but not over longer follow-up. Preoperative frailty is associated with an increased risk of death after lung transplantation.
K E Y W O R D S
clinical research/practice, lung transplantation/pulmonology, patient survival, recipient selection score ranging from 0 to 12. Lower SPPB scores reflect increased frailty. Consistent with established definitions and our prior work, we defined frailty as an SPPB score of ≤7. 4, 6 The FFP is an aggregate score of 5 constructs: low physical activity, slowness, weakness, shrinking, and exhaustion. 23 Over the study period, early participants completed only the MLTA survey, others both the MLTA and DASI, and later subjects only the DASI. For subjects who had completed the DASI survey, we defined low activity by this metric (termed "FFP-DASI");
for earlier subjects who had only completed the MLTA survey, we defined low activity by MLTA ("FFP-MLTA"). Services. As a result, we had no missing data for any of the covariates.
| Confounding and precision variables
| Outcome measures
Since we hypothesized that preoperative frailty was most likely to influence early death, we defined survival time within the first postoperative year as our primary outcome. Dates of death were obtained through medical record review. Survival time was calculated as the number of days from the date of lung transplantation until the date of death. For 1-year survival, survival time was rightcensored at 365 days. We also performed secondary analyses evaluating whether preoperative frailty-as either a binary (frail or not)
or continuous variable-was associated with longer-term mortality.
Due to few subjects with follow-up time >4 years, we restricted our longer-term survival analysis to 4 years and right-censored survival time at 1460 days. We also tested whether preoperative frailty was associated with length of index hospitalization stay.
| Analysis approach
The unadjusted associations of frailty with death after transplantation were visually assessed with Kaplan-Meier methods and compared using the log rank test. For subsequent adjusted models, a modest number of deaths within the first year after transplant could have required us to consider a parsimonious list of covariates. To address this, we controlled for potential confounders and precision variables by generating propensity scores predicting frailty status.
Variables used to generate the propensity score included age, sex, race/ethnicity, diagnosis, FVC, BMI, 6MWD, and LAS. We utilized the STATA "pscore.ado" program (15.1; StataCorp, College Station, TX) to generate propensity scores and confirm that the covariate balancing hypothesis was satisfied. 24, 25 We used multivariable stratified Cox proportional hazard models to estimate the association between preoperative frailty and death within the first year after transplant. We first examined the unadjusted association between frailty and mortality with 1 stratum for each transplant center.
Next, we included the propensity score in the subsequent adjusted models. Lastly, we conducted a series of sensitivity analyses. In one analysis, we included the LAS at the time of lung transplantation as a covariate in the propensity score-adjusted models. In a subsequent analysis, we included change in LAS from the time of listing to the time of transplant as a covariate in the propensity score-adjusted models. Next, we tested the association between frailty and mortality after transplant differed in the era before or after the February 15, 2015 update to the LAS scoring algorithm. In a fourth sensitivity analysis, we excluded subjects (n = 17) with frailty assessments that were >9 months from the date of transplant. Finally, we included the need for extracorporeal membrane oxygenation or invasive mechanical ventilation as a bridge to lung transplantation as a covariate in the propensity score-adjusted models. To evaluate the proportionality of hazards, we plotted scaled Schoenfeld residuals with respect to time, assessed log-negative-log plots, and used the Schoenfeld test. Length of incident hospital stay was compared with Wilcoxon rank sum.
We calculated postestimation marginalized standardized risks for death within the first year using logistic regression models with frailty as an independent variable and death as the dependent variable, controlling for center and the propensity score that did not include BMI or 6MWD.
Analyses were performed using Stata (15.1; StataCorp). For all analyses, we used a P value of <.05 as the threshold for statistical significance.
| RE SULTS
A total of 386 subjects with preoperative frailty assessments underwent lung transplantation and were included in this cohort. A total of 20% of the subjects were frail by our primary definition using the SPPB (95% confidence interval [CI]: 16-25; Table 1 ). (Table 1) .
Nineteen subjects died within the first year after lung transplantation; of these 10 were women. Causes of death included infection (n = 7), primary graft dysfunction (n = 4), acute rejection or chronic allograft dysfunction (n = 3), cardiovascular events (n = 2), and other (n = 2). In unadjusted analyses, preoperative frailty was associated with a 10-fold increase in the risk of death during the first year after lung transplantation (hazard ratio [HR]: 10.5; 95% CI: 2.9-37.9; Table 2 ; Figure 1A ). In the propensity score-adjusted model, frailty was associated with a 9.5-fold increased risk of death (HR 9.7; 95% CI: 2.4-38.9; Table 2 ). Over the entire study 95% CI: 1.08-1.33 for propensity score-adjusted model). Adding LAS as a covariate to the propensity score-adjusted models did not appreciably change our findings (Table 2 ). Our findings were also generally not substantially different across 5 sensitivity analyses (Tables S2-5 ). The exception was a stronger association between FFP frailty and 1-year mortality when controlling for the need for preoperative extracorporeal membrane oxygenation or invasive mechanical ventilation as a bridge to lung transplantation (Table S5) .
Based on the calculated standardized predicted risk of death in the first year after lung transplantation, frail subjects had a propensity score-adjusted 13.7% absolute risk of death (95% CI:
3.2%-24%) compared to 1.5% in those who were not frail (95% CI:
0.03%-3.0%)-an absolute risk increase of 12.2% (95% CI: 3.1%-21%) (Figure 2 ).
In our secondary analysis in which we defined frailty by the FFP, 33% of subjects were frail before transplantation (95% CI: 28, 39%). FFP frailty was associated with a >3.5-fold increased risk of death within the first year after transplant, adjusting for propensity score (HR: 3.8; 95% CI: 1.1-13.2) ( Figure 3A and Table 3 ). In contrast to the SPPB, the association between FFP frailty and death over 4 years of follow-up varied over time and violated the proportionality assumption, precluding log rank testing or using Cox proportional hazard models ( Figure 3B and 
| D ISCUSS I ON
In this US-based multicenter prospective cohort study, we found that frailty, defined by the SPPB, was common among lung transplant candidates and was independently associated with an increased risk for early mortality following lung transplantation.
Beyond the increased relative risk, those who were frail before lung transplantation had an absolute increased risk of death within the first postoperative year of 12% compared to those who were not frail. Additionally, each 1-point worsening in preoperative SPPB was associated with a 20% increased risk of longer-term death after lung transplantation. In secondary analyses, we found that frailty defined by the FFP was independently associated with 1-year, but not longer-term, mortality following lung transplantation.
Given the scarcity of donor organs, especially in lung transplantation in which only <30% of donor lungs are accepted, efforts to reduce mortality after transplantation are fundamental to maximizing the individual and societal benefit of transplantation. 26 Applying concepts and principles from the aging literature to lung and other solid organ transplantation is becoming increasingly relevant to clinical care and, potentially, organ allocation policy. Adults ≥65 years of age now represent nearly 30% of new lung transplant recipients, up from 4% in 2002. 1 Similar trends have been observed in heart, liver, and kidney transplantation. [27] [28] [29] In the last 5 years, frailty measured by the SPPB and/or FFP has been shown to be associated with an increased risk of death among lung, heart, and liver transplant candidates. 4, 16, 18 In addition, frailty is associated with delayed graft function, length of stay following transplant surgery, hospital readmission, and mortality after kidney transplantation. 15, 17, [30] [31] [32] Also, in a single center retrospective study, frailty quantified by the cumulative index model was associated with mortality after lung transplantation. 19 This study and our prior work demonstrating that frailty is independently associated with waitlist and posttransplant mortality across age groups adds to this emerging body of work.
4
That the prevalence of frailty in solid organ transplantation ranges from 10% to 43% inclusive of younger candidates suggests that the biology driving pathologic aging may be operational across the age spectrum. 4, [15] [16] [17] [18] [31] [32] [33] [34] Work starting to tease apart the pathobiology of frailty, including chronic inflammation, neurohormonal failure, sarcopenia, and epigenetics could provide mechanistic insights and potentially explain part of the association between clinical frailty and mortality. 4, [35] [36] [37] [38] [39] The putative mechanisms causing frailty are multiple, however, and reflect the complexity of the aging process. frailty scores. [58] [59] [60] In a study of patients with COPD referred for pulmonary rehabilitation, 26% were frail by the FFP measure. Although frailty was associated with a 2-fold higher odds of failing to complete the 8-week program, among those who did, 61% were no longer frail on repeat assessment. We performed a pilot home-based exercise The association of frailty and death over up to 4 y of follow-up violated the assumption of proportional hazards, so HRs were not estimated. b Propensity score includes age, sex, race/ethnicity, diagnosis, forced vital capacity, body mass index, and 6-min walk distance.
TA B L E 3 Association between FFP frailty and death within the first year after lung transplantation (n = 299) a and nutrition intervention study to treat frailty in lung transplant candidates using a novel mobile health-based program. In 15 subjects with COPD or pulmonary fibrosis, we reported in abstract form that treating frailty was safe and, for some of the participants, SPPB frailty scores improved. 61 These studies suggest that implementing targeted interventions before transplantation to optimize preoperative functional status (ie, "prehabilitation") could reverse components of the frailty phenotype; ideally, doing so would then reduce subsequent morbidity and mortality. [62] [63] [64] Our study had limitations and also raises several important questions that identify important areas for future research efforts focused on frailty in advanced lung disease and lung transplantation. The limited number of deaths precluded us from performing clinically important stratified analyses such as by age group or diagnosis, or testing for multiplicative interaction terms. Due to the timing of study initiation at each center, both SPPB and FFP measures were not collected in all subjects. In addition, as evidenced by the wide confidence intervals around estimates of the mortality risk associated with SPPB and FFP frailty, the point estimates of risk should be cautiously interpreted. Additional investigation is needed to understand the specific mechanisms by which frailty increases the risk of death after lung transplant. Furthermore, the 1-year mortality rate of 5% is lower than the national average, now at approximately 11%. candidates. 23 Although we previously demonstrated both the FFP-DASI and FFP-MLTA measures to be valid in advanced lung disease 4 and combining the 2 enriches our sample size and reduces missing data, it is possible that the hybrid measure could contribute to misclassification of frailty by FFP and thereby influence the differential association between SPPB and FFP frailty and risk of mortality after lung transplantation. While the point estimates of mortality risk associated with either the FFP-DASI or FFP-MTLA were similar to our composite measure in both unadjusted and propensity score models, we cannot exclude the potential for misclassification. Finally, due to the limited number of repeated assessments before lung transplant, we were unable to evaluate whether a change in frailty score before transplant was associated with mortality after lung transplantation. It is plausible that acute worsening in frailty scores, regardless of the absolute value, could identify patients at increased risk of poor outcomes, as has been shown for changes in 6MWD and the LAS.
In conclusion, frailty is prevalent in lung transplant candidates and is strongly associated with an increased risk of early mortality following transplant surgery. Since frailty is also associated with mortality before lung transplantation, efforts are needed determine how to include these measures in the assessment of lung transplant candidacy and organ allocation.
